Results 191 to 200 of about 5,115,447 (250)

Emerging Immune‐Based Therapeutic Strategies in Hepatocellular Carcinoma

open access: yesLiver International, Volume 46, Issue 8, August 2026.
ABSTRACT Hepatocellular carcinoma (HCC) remains a leading cause of cancer‐related mortality worldwide despite recent advances in systemic therapy. The introduction of immune checkpoint inhibitors has substantially expanded treatment options for advanced disease; however, durable responses are observed only in a subset of patients.
Janine Kah   +2 more
wiley   +1 more source

NOS2/ARG1 axis and immune cell ratios as promising prognostic and predictive biomarkers for Cetuximab combined with chemotherapy in wt-KRAS human colorectal cancer. [PDF]

open access: yesFront Immunol
Mataam DH   +14 more
europepmc   +1 more source

Pegzilarginase in Arginase 1 Deficiency: Clinical and Biochemical Effects of Treatment Initiation, Discontinuation and Re-Initiation. [PDF]

open access: yesChildren (Basel)
Faraguna MC   +10 more
europepmc   +1 more source

Biochemistry of amphibian metamorphosis. II. Arginase activity.

open access: yesThe Journal of biological chemistry, 2003
J L, DOLPHIN, E, FRIEDEN
openaire   +1 more source

Increased Glucose Availability Sensitizes Pancreatic Cancer to Macrophage-Targeting Immunotherapies. [PDF]

open access: yesCancer Res Commun
Hue JJ   +18 more
europepmc   +1 more source

BCR-ABL1 Drives Transcriptional Reprogramming of Chronic Myeloid Leukemia Cells for Immune Evasion Through C/EBPβ. [PDF]

open access: yesMedComm (2020)
Lu X   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy